Luciano Morganti Paladini

Produções bibliográficas

• Paladini, Luciano ; DA VEIGA, CÁSSIA RITA PEREIRA ; CERQUEIRA, ÉRICA ; CHABROL HAAS, LAURA ; DATZ ABADI, MÁRCIA ; BALDOTTO, CLARISSA SERÓDIO . Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer. Journal of Medical Economics , v. 1, p. 1-21, 2021.

• GREENE, MALLIK ; Paladini, Luciano ; LEMMER, TERESA ; PIEDADE, ALEXANDRA ; TOUYA, MAELYS ; CLARK, OTAVIO . Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatric Disease and Treatment , v. Volume 14, p. 1545-1559, 2018.

• Botrel, Tobias Engel Ayer ; CLARK, LUCIANA GONTIJO DE OLIVEIRA ; Paladini, Luciano ; Clark, Otávio Augusto C. . Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis. BMC CANCER , v. 16, p. 677, 2016.

• PIEDADE, A ; PALADINI, L ; TOBARUELLA, F ; NAKADA, C . Cost-Minimization Analysis Of Rivaroxaban In Comparison To Enoxaparin Plus Warfarin For The Treatment Of Venous Thromboembolism (Vte) Under The Private Healthcare System Perspective. VALUE IN HEALTH , v. 18, p. A394-A395, 2015.

• PIEDADE, A ; PALADINI, L ; TOBARUELLA, F ; NAKADA, C . Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System. VALUE IN HEALTH , v. 18, p. A383-A384, 2015.

• Mhaskar, Rahul ; Clark OA ; Lyman G ; Engel Ayer Botrel T ; Morganti Paladini L ; Djulbegovic B . Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Cochrane Database of Systematic Reviews , v. 10, p. CD003039, 2014.

• Clark, Otávio ; BOTREL, TOBIAS ; Paladini, Luciano ; FERREIRA, MARIANA . Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis. Core Evidence , v. 2014:9, p. 1-11, 2014.

• BOTREL, TOBIAS ; Clark, Otávio ; Paladini, Luciano . Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis. Core Evidence , v. 8, p. 69, 2013.

• NISHIKAWA, ALVARO MITSUNORI ; Paladini, Luciano ; DELFINI, REGIS ; KOTZE, PAULO GUSTAVO ; CLARK, OTAVIO . DECISION TREE CONSTRUCTION AND COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF ULCERATIVE COLITIS WITH PENTASA® MESALAZINE 2 G SACHET. ARQUIVOS DE GASTROENTEROLOGIA (IMPRESSO) , v. 50, p. 297-303, 2013.

• 6 2011 Clark, Otávio Augusto C. ; Clark, Luciana ; Paladini, Luciano ; Faleiros, Enéas ; Pegoretti, Bruna . Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis. Supportive Care in Cancer , v. 19, p. 823-832, 2011.

• Botrel, Tobias Engel Ayer ; Clark, Otávio ; Clark, Luciana ; Paladini, Luciano ; Faleiros, Enéas ; Pegoretti, Bruna . Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): Systematic review and meta-analysis. Lung Cancer , v. 74, p. 89-97, 2011.

• PALADINI, L. ; PEPE, C. ; Clark, Otávio Augusto C. ; TENCER, T. ; KHAN, Z. . ECONOMIC EVALUATION OF AZACITIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS). In: ISPOR 17TH ANNUAL INTERNATIONAL MEETING, 2012, Washington DC. ISPOR 17TH ANNUAL INTERNATIONAL MEETING RESEARCH ABSTRACTS, 2012. v. 15. p. A212-A212.

• PEPE, C. ; PALADINI, L. ; SEDLMAYER, C. ; MACHADO, M. . COST-EFFECTIVENESS OF PAZOPANIB VERSUS SUNITINIB AND BEVACIZUMAB ASSOCIATED TO INTERFERON ALPHA AS FIRST LINE TREATMENTS FOR METASTATIC RENAL CELL CARCINOMA. In: ISPOR 17TH ANNUAL INTERNATIONAL MEETING, 2012, Washington DC. ISPOR 17TH ANNUAL INTERNATIONAL MEETING RESEARCH ABSTRACTS, 2012. v. 15. p. A218-A218.

• HAUN, M. A. D. ; Clark, Otávio ; PALADINI, L. ; TEICH, V. ; MATHEUS, W. ; FERREIRA, U. . COLONY STIMULATING FACTORS (CSF) FOR THE TREATMENT OF FEBRILE NEUTROPENIA (FN) IN CANCER PATIENTS: A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: Health Technology assessment International - 8th annual meeting, 2011, Rio de Janeiro. Health Technology assessment International - 8th annual meeting Book of abstracts, 2011.

• PALADINI, L. ; Clark, Otávio ; AYER, B. T. E. ; Clark, Luciana . GEFTINIB (G) VERSUS CONVENTIONAL CHEMOTHERAPY (CT) FOR THE 1ST LINE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTORS MUTATION (EGFRM): A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: Health Technology assessment International - 8th annual meeting, 2011, Rio de Janeiro. Health Technology assessment International - 8th annual meeting Book of abstracts, 2011.

• Clark, Luciana ; AYER, B. T. E. ; Clark, Otávio ; PALADINI, L. . PLATIN COMPOUNDS (PC) PLUS TAXANES (T) AGAINST T ALONE FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC): A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: Health Technology assessment International - 8th annual meeting, 2011, Rio de Janeiro. Health Technology assessment International - 8th annual meeting Book of abstracts, 2011.

• PEPE, C. ; MARINHO, T. ; MACHADO, M. ; BLUNK, V. ; PALADINI, L. . COST-EFFECTIVENESS OF LAPATINIB COMBINED WITH HORMONE THERAPY IN PATIENTS WITH HER2+/ HORMONE RECEPTORS POSITIVE (HR+) METASTATIC BREAST CANCER (MBC) IN BRAZIL. In: Health Technology assessment International - 8th annual meeting, 2011, Rio de Janeiro. Health Technology assessment International - 8th annual meeting Book of abstracts, 2011.

• AYER, B. T. E. ; PALADINI, L. ; Clark, Otávio ; Clark, Luciana . INTERMITTENT VERSUS CONTINUOUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF UNRESECTABLE METASTATIC COLORECTAL CANCER (CCRM): SYSTEMATIC REVIEW AND META-ANALYSIS. In: ISPOR 14TH ANNUAL EUROPEAN CONGRESS, 2011, Madrid. Value in Health - ISPOR 14TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS, 2011. v. 14.

• Clark, Otávio ; Clark, Luciana ; AYER, B. T. E. ; PALADINI, L. ; MEDINA, P. ; Pegoretti, Bruna . CAPECITABINE FOR THE TREATMENT OF COLORECTAL CANCER IN PRIVATE HEALTH SYSTEM IN BRAZIL: A BUDGETARY IMPACT ANALYSIS BASED ON REAL WORLD DATA. In: ISPOR 14TH ANNUAL EUROPEAN CONGRESS, 2011, Madrid. Value in Health - ISPOR 14TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS, 2011. v. 14.

• Clark, Otávio ; Clark, Luciana ; Botrel, Tobias Engel Ayer ; MEDINA, P. ; PALADINI, L. . BUDGETARY IMPACT OF ADOPTION OF ERLOTINIB FOR LUNG CANCER IN THE PRIVATE HEALTH INSURANCE MARKET IN BRAZIL: A REAL WORLD DATA ANALYSIS. In: ISPOR 14TH ANNUAL EUROPEAN CONGRESS, 2011, Madrid. Value in Health - ISPOR 14TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS, 2011. v. 14.

• PALADINI, L. M.; Clark, Otávio Augusto C. ; Clark, Luciana ; Pegoretti, Bruna ; Botrel, Tobias Engel Ayer ; Faleiros, Enéas . REAL WORLD DATA ON MULTIFRACTION (MFR) VERSUS SINGLE FRACTION (SFR) RADIOTHERAPY TO TREAT BONE METASTASIS: IMPACT IN COSTS FOR PRIVATE HEALTH CARE (PHC) PROVIDERS IN BRAZIL. In: ISPOR Fifteenth Annual International Meeting Research Abstracts, 2010, Atlanta. Value In Health, 2010. v. 13.

• AYER, B. T. E. ; Clark, Otávio ; Clark, Luciana ; PALADINI, L. M. ; Faleiros, Enéas ; Pegoretti, Bruna . EFFICACY AND CARDIAC SAFETY OF TRASTUZUMAB (T) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY-STAGE BREAST CANCER: A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: ISPOR 13th Annual European Congress, 2010, Prague. Value In Health, 2010. v. 13.

• Botrel, Tobias Engel Ayer ; Clark, Otávio ; Clark, Luciana ; PALADINI, L. ; Faleiros, Enéas ; Pegoretti, Bruna . EFFICACY OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE (GEM) COMPARED TO SURGERY-ONLY IN PATIENTS WITH RESECTED PANCREATIC CANCER: SYSTEMATIC REVIEW (SR) AND META- ANALYSIS (MA). In: ISPOR 13th Annual European Congress, 2010, Prague. value in Health - ISPOR 13th Annual European Congress Research Abstracts, 2010. v. 13.

• Botrel, Tobias Engel Ayer ; Clark, Otávio ; Clark, Luciana ; Faleiros, Enéas ; PALADINI, L. ; Pegoretti, Bruna . EFFICACY OF THE COMBINATION BEVACIZUMAB PLUS CHEMOTHERAPY (BEV-CT) COMPARED TO CT ALONE IN PREVIOUSLY UNTREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: ISPOR 13th Annual European Congress, 2010, Prague. Value in Health - ISPOR 13th Annual European Congress Research Abstracts, 2010. v. 13.

• Botrel, Tobias Engel Ayer ; Clark, Otávio ; PALADINI, L. ; Clark, Luciana ; Faleiros, Enéas ; Pegoretti, Bruna . BUDGETARY IMPACT OF ORAL CHEMOTHERAPY: REAL-WORLD DATA ANALYSIS FROM PAYERS? PERSPECTIVES IN BRAZIL. In: ISPOR Twelfth Annual European Congress, 2009, Paris. Value in Health - ISPOR Twelfth Annual European Congress Research Abstracts, 2009. v. 12.

• Botrel, Tobias Engel Ayer ; Clark, Otávio ; PALADINI, L. ; Faleiros, Enéas ; Clark, Luciana ; Pegoretti, Bruna . TWO DIFFERENT DOSES OF PALONOSETRON (PAL) FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING (CIV) IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC (MOHE) TREATMENT: SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA). In: ISPOR Twelfth Annual European Congress, 2009, Paris. Value in Health - ISPOR Twelfth Annual European Congress Research Abstracts, 2009. v. 12.

• PALADINI, L. ; Clark, Otávio ; Clark, Luciana ; Botrel, Tobias Engel Ayer ; Faleiros, Enéas . 4. Erythropoiesis Stimulating Agents (ESAs) for the treatment of chemotherapy induced anemia in patients with hemoglobin levels (Hb) <11g/dl. A systematic review and meta-analysis. In: 50th Annual Meeting - American Society of Hematology, 2008, San Francisco. Blood - American Society of Hematology - 50th Annnual Meeting and Exposition Program Book, 2008. v. 2008.

Prêmios